| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.54 | 0.002 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.43 | 0.003 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |